Page 29 - 《中国药房》2024年14期
P. 29

of  the  Central  Military  Commission. Prescription  review   理学会药源性疾病学专业委员会,药物不良反应杂志社,
              standards  for  medical  institutions[EB/OL].(2018-07-10)  等. 医疗机构围手术期镇痛药使用的风险防范与管理指
              [2024-01-10]. http://www.nhc.gov.cn/yzygj/s7659/2018-  导原则[J]. 药物不良反应杂志,2022,24(8):396-403.
              07/de5c7c9116b547af819f825b53741173.shtml.          The  International  Network  of  Rational  Drug  Use  China
          [ 3 ]  程凯,王欢,杜春晓,等. 信息系统辅助抗肿瘤药物处方                       Center Group Clinical Safety Drug Use Group,the Professio-
              审核分析[J]. 医药导报,2024,43(1):47-53.                     nal Committee of Pharmacological Diseases of the Chinese
              CHENG K,WANG H,DU C X,et al. Analysis of review     Pharmacological Society,Journal of Adverse Drug Reac‐
              of  anti-tumor  drug  prescriptions  assisted  by  information   tions,et al.Guidelines for prevention and management of
              system[J]. Her Med,2024,43(1):47-53.                perioperative analgesics use in medical institutions[J]. Ad‐
          [ 4 ]  张婷,顾婕,丁兰萍,等. 医疗机构中药处方前置审核规                       verse Drug React J,2022,24(8):396-403.
              则的优化与实践[J]. 中国药房,2022,33(12):1506-1512.        [12]  广东省药学会. 临床药师术后疼痛管理指引[J]. 今日药
              ZHANG T,GU J,DING L P,et al. Optimization and prac‐  学,2019,29(4):217-227.
              tice  in  pre-review  rules  of  traditional  Chinese  medicine   Guangdong  Pharmaceutical  Association. Guidelines  for
              prescription  in  medical  institutions[J].  China  Pharm,  postoperative pain management of clinical pharmacists[J].
              2022,33(12):1506-1512.                              Pharm Today,2019,29(4):217-227.
          [ 5 ]  LAWTON  J  S,TAMIS-HOLLAND  J  E,BANGALORE   [13]  蔡学菊,刘立民,王羡欠,等. 全程化手术室麻醉药品管
              S,et  al.  2021  ACC/AHA/SCAI  guideline  for  coronary      理体系的构建[J]. 药品评价,2023,20(5):599-603.
              artery revascularization:a report of the American College   CAI X J,LIU L M,WANG X Q,et al. Construction of a
              of Cardiology/American Heart Association Joint Commit‐  comprehensive narcotic drugs management system for ope-
              tee  on  clinical  practice  guidelines[J].  Circulation,2022,  rating rooms[J]. Drug Eval,2023,20(5):599-603.
              145(3):e18-e114.                               [14]  张旭锋,史香芬,卢晓静,等. 基于门诊处方前置审核系
          [ 6 ]  中华医学会心血管病学分会,中华心血管病杂志编辑委                         统的麻醉药品和精神药品用药规则精细化设置与实施
              员会. 非心脏外科手术围手术期心血管疾病管理中国专                           效果评价[J]. 中国医院药学杂志,2022,42(9):935-939.
              家共识[J]. 中华心血管病杂志,2023,51(10):1043-1055.             ZHANG  X  F,SHI  X  F,LU  X  J,et  al.  Fine  setting  and
              Cardiovascular  Branch  of  the  Chinese  Medical  Associa‐  implementation effects evaluation of the use rules for nar‐
              tion,Editorial Committee of the Chinese Journal of Car‐  cotic  drugs  and  psychotropic  drugs  based  on  outpatient
              diovascular  Disease.  Chinese  expert  consensus  on  peri-  prescription  pre-review  system[J].  Chin  J  Hosp  Pharm,
              operative  cardiovascular  assessment  and  management  of    2022,42(9):935-939.
              patients undergoing non-cardiac surgery[J]. Chin J Cardiol,  [15]  XIE H,ZHANG H X,PENG J,et al. Prospective prescrip‐
              2023,51(10):1043-1055.                              tion  review  system  promotes  safe  use  of  analgesics,im‐
          [ 7 ]  广东省药学会. 关于发布《超药品说明书用药目录(2023                     proves clinical outcomes,and saves medical costs in surgi‐
              年 版)》的 通 知 [EB/OL].(2023-07-04)[2024-01-10].        cal patients:insights from Nanjing Drum Tower Hospital
              http://www.sinopharmacy.com.cn/notification/2797.html.  [J]. Adv Ther,2022,39(1):441-454.
              Guangdong Pharmaceutical Association.Notice on issuing   [16]  陈慧,王诗卉,张东肃,等. 北京某三级综合医疗机构实
              the  Catalogue  of  Medications  for  Off-Label  Drug  Use  施处方前置审核效果[J]. 医药导报,2020,39(9):1203-
              (2023  Edition) [EB/OL]. (2023-07-04) [2024-01-10].   1205.
              http://www.sinopharmacy.com.cn/notification/2797.html.  CHEN  H,WANG  S  H,ZHANG  D  S,et  al.  Effect  and
          [ 8 ]  PLAUD B,BAILLARD C,BOURGAIN J L,et al. Guide‐    practice  of  pre-prescription  review  in  a  third-level  medical
              lines  on  muscle  relaxants  and  reversal  in  anaesthesia[J].   institution in Beijing[J]. Her Med,2020,39(9):1203-1205.
              Anaesth Crit Care Pain Med,2020,39(1):125-142.  [17]  FAN X C,CHEN D X,BAO S W,et al. Prospective pre‐
          [ 9 ]  黑子清,黄文起,刘克玄,等. 麻醉前应用抗胆碱能药物                       scription review system correlated with more rational PPI
              的广东省专家共识:2021版[J]. 广东医学,2021,42(11):                medication use,better clinical outcomes and reduced PPI
              1290-1294.                                          costs:experience  from  a  retrospective  cohort  study[J].
              HEI Z Q,HUANG W Q,LIU K X,et al. The 2021 edition   BMC Health Serv Res,2023,23(1):1014.
              of expert consensus of Guangdong province on the use of   [18]  魏娜,吴朝阳,陈伦灼,等. 基于循证证据的我院出院带
              anticholinergic  drugs  before  anesthesia[J].  Guangdong   药处方前置审核系统的运行实践[J]. 中国药房,2020,31
              Med J,2021,42(11):1290-1294.                       (15):1910-1915.
          [10]  徐建国,黄宇光,邓小明,等. 地佐辛术后镇痛专家建议:                       WEI N,WU Z Y,CHEN L Z,et al. Evidence-based opera‐
              2018[J]. 临床麻醉学杂志,2018,34(7):712-715.                tion  practice  of  pre-audit  system  of  discharged  prescrip‐
              XU J G,HUANG Y G,DENG X M,et al. Expert advice      tions in our hospital[J]. China Pharm,2020,31(15):1910-
              on postoperative analgesia with dezocine:2018[J]. J Clin   1915.
              Anesthesiol,2018,34(7):712-715.                               (收稿日期:2024-01-19  修回日期:2024-04-12)
          [11]  合理用药国际网络中国中心组临床安全用药组,中国药                                                          (编辑:舒安琴)



          中国药房  2024年第35卷第14期                                              China Pharmacy  2024 Vol. 35  No. 14    · 1695 ·
   24   25   26   27   28   29   30   31   32   33   34